We also found that the positive expression rates of LDHC mRNA in serum and serum-derived exosomes of BC patients were 91.66% and 87.50%, respectively, and that circulating LDHC can be used for the diagnosis, efficacy evaluation, and recurrence monitoring of BC (14). The gene discussed is LDHC; the disease is breast cancer.